Position in ALEC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,879,683
-$888,852 QoQ
Shares Held
935,166
-27.4% QoQ
Ownership
0.838%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 140 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. ALEC ranks #137 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ALEC
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,879,683 | 935,166 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,768,535 | 1,287,691 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,408,094 | 1,543,650 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,809,484 | 949,150 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,756,790 | 1,254,850 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,271,641 | 1,033,855 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,730,744 | 915,738 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,617,755 | 561,750 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,973,927 | 655,050 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,066,407 | 675,483 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,564,424 | 571,983 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,254,275 | 502,203 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,129,368 | 687,083 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,023,258 | 649,961 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,462,424 | 591,812 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,816,715 | 720,583 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,820,483 | 966,583 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $10,057,365 | 705,780 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,647,362 | 273,480 | Shares | Sole | 2022-02-11 | |
| 2020-06-30 | $1,705,423 | 69,780 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||